Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2024 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3708-3821
Open Access | Times Cited: 477

Showing 1-25 of 477 citing articles:

Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management
Baljinder Singh, Candace M. Day, Sadikalmahdi Abdella, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 402-424
Open Access | Times Cited: 41
The role of the Mediterranean diet in reducing the risk of cognitive impairement, dementia, and Alzheimer’s disease: a meta-analysis
Mónika Fekete, Péter Varga, Zoltán Ungvári, et al.
GeroScience (2025)
Open Access | Times Cited: 2
INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's disease
Eric Siemers, Todd Feaster, Gopalan Sethuraman, et al.
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 1, pp. 100005-100005
Open Access | Times Cited: 1
CEST imaging combined with 1H-MRS reveal the neuroprotective effects of riluzole by improving neurotransmitter imbalances in Alzheimer’s disease mice
Yuanyu Shen, Xiaolei Zhang, Si-qi Liu, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Statin use and dementia risk: A systematic review and updated meta‐analysis
Fernando Luiz Westphal Filho, Paulo Roberto Moss Lopes, Artur Menegaz de Almeida, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Mitochondrial dysfunction in Alzheimer's disease: Guiding the path to targeted therapies
Kyle C McGill Percy, Zhenguo Liu, Xin Qi
Neurotherapeutics (2025), pp. e00525-e00525
Open Access | Times Cited: 1
Comprehensive Dementia Care Models: State of the Science and Future Directions
Komal Patel Murali, Joan G. Carpenter, Ann Kolanowski, et al.
Research in Gerontological Nursing (2025) Vol. 18, Iss. 1, pp. 7-16
Closed Access | Times Cited: 1
miR‐32533 Reduces Cognitive Impairment and Amyloid‐β Overload by Targeting CREB5‐Mediated Signaling Pathways in Alzheimer's Disease
Li Zeng, Zhongdi Cai, Jianghong Liu, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Inhibition of soluble epoxide hydrolase ameliorates cerebral blood flow autoregulation and cognition in alzheimer's disease and diabetes-related dementia rat models
Chengyun Tang, Jane J. Border, Huawei Zhang, et al.
GeroScience (2025)
Open Access | Times Cited: 1
Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US
William Yang Wang, QuangQiu Wang, Xin Qi, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 13
Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status
Haoshen Shi, Nazanin Mirzaei, Yosef Koronyo, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access | Times Cited: 10
A Review of the Current Status of Disease-Modifying Therapies and Prevention of Alzheimer’s Disease
Dinah V. Parums
Medical Science Monitor (2024) Vol. 30
Open Access | Times Cited: 8
Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut−brain axis
Yoonsu Kim, Jinkyu Lim, Jisun Oh
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117277-117277
Closed Access | Times Cited: 8
Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges
Jacky Tran, Sneh Parekh, Julia Rockcole, et al.
Life Sciences (2024) Vol. 355, pp. 123001-123001
Closed Access | Times Cited: 8
Advancements and Challenges in Antiamyloid Therapy for Alzheimer’s Disease: A Comprehensive Review
Semira Abdi Beshir, Nadia Hussain, Vineetha Bharathan Menon, et al.
International Journal of Alzheimer s Disease (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 6
Immunotherapy: An emerging treatment option for neurodegenerative diseases
Abhiyanta Mukherjee, Soumojit Biswas, Ipsita Roy
Drug Discovery Today (2024) Vol. 29, Iss. 5, pp. 103974-103974
Closed Access | Times Cited: 5
Comprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation Strategies
Manish Kumar Singh, Yoonhwa Shin, Songhyun Ju, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6901-6901
Open Access | Times Cited: 5
Plasma proteins associated with the brain age gap
Erik C. B. Johnson
Nature Aging (2025)
Closed Access
Synthesis and biological evaluation of novel pyrrolo[2,3-b]pyridine derivatives as potent GSK-3β inhibitors for treating Alzheimer's disease
Qingqing Xun, Jing Zhang, Yan-Peng Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117236-117236
Closed Access
Peripheral Single‐Cell Immune Characteristics Contribute to the Diagnosis of Alzheimer's Disease and Dementia With Lewy Bodies
Conglong Qiu, Danhua Zhang, Majie Wang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 1
Open Access
Multi-target-directed therapeutic strategies for Alzheimer’s disease: controlling amyloid-β aggregation, metal ion homeostasis, and enzyme inhibition
Jeasang Yoo, Jimin Lee, Byeongha Ahn, et al.
Chemical Science (2025)
Open Access
Integrating GWAS and Transcriptome Data through PrediXcan and Multimodal Deep Learning to Reveal Genetic Basis and Novel Drug Repositioning Opportunities for Alzheimer's Disease
Xuecong Tian, Ying Su, Sizhe Zhang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Senescent brain cell types in Alzheimer's disease: Pathological mechanisms and therapeutic opportunities
Hannah R. Hudson, Xuehan Sun, Miranda E. Orr
Neurotherapeutics (2025), pp. e00519-e00519
Open Access
The needs of informal caregivers of people experiencing dementia as identified on social media
Jane Flanagan, Maureen Connolly, Amanda Bulette Coakley, et al.
Aging & Mental Health (2025), pp. 1-8
Closed Access
Threshold effects of sleep duration and cognitive function in older adults with BMI ≥ 25 kg/m2
Kunyu Qiu, Yilei Liu, Chengwei Hu, et al.
Frontiers in Aging Neuroscience (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top